Mechanism of positive allosteric modulators acting on AMPA receptors
The investigators identified a binding site for aniracetam in the GluR2 ligand-binding domain. Mutations affecting that site disrupted modulation, supporting a relationship between the observed structure and receptor behavior.
Reading limit: This is mechanistic evidence from experimental receptor systems. It does not measure clinical benefit or long-term safety.
